Endovascular Specialists treat vascular conditions through minimally invasive techniques aimed at the blood vessels. They handle a wide range of disorders, such as aneurysms, peripheral artery disease (PAD), carotid artery disease, and varicose veins. These specialists perform procedures like angioplasty, stenting, and endovenous laser therapy to repair or treat damaged blood vessels without the need for open surgery. Their goal is to restore proper blood flow, alleviate symptoms, and prevent severe complications like strokes, heart attacks, or limb loss. These techniques offer benefits such as reduced recovery time, fewer risks, and smaller incisions compared to traditional surgeries. The use of advanced imaging technology ensures precise treatment, leading to better outcomes for patients.
Along with treating existing vascular issues, endovascular specialists also focus on preventing the progression of vascular diseases. They work closely with patients to manage risk factors, such as high cholesterol, hypertension, diabetes, and smoking, which can worsen vascular health. By recommending lifestyle changes, prescribing medications, and providing regular follow-up care, endovascular specialists help slow disease progression and reduce the likelihood of future complications. Their comprehensive approach to care not only aids in recovery but also ensures that patients maintain long-term vascular health, improving overall quality of life and reducing the chances of future cardiovascular events.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India